SEC Form 4 · accession 0001209191-15-029542
IMMUNIC, INC. · IMUX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Errol R. Halperin
Director
Period of report
Mar 24, 2015
Accepted (ET)
Mar 26, 2015 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280776
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $26.13 | Mar 24, 2015 | A | 5,604 | A | — | Mar 23, 2025 | Common Stock | 5,604 | 5,604 | D |
Explanation of responses
- F1Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through the vesting date, 100% of the shares subject to the option shall vest and become exercisable upon the earlier of the one (1) year anniversary from March 24, 2015 or the day prior to the Company's 2016 annual meeting of stockholders.